Modulating the sEH/EETs Axis Restrains Specialized Proresolving Mediator Impairment and Regulates T Cell Imbalance in Experimental Periodontitis.
Henrique B AbdallaLuciano Eduardo PuhlCarla Alvarez RivasYu-Chiao WuPaola RojasCarlos Antonio Trindade-da-SilvaBruce D HammockKrishna Rao MaddipatiMariana Quirino Silveira SoaresJuliana Trindade Clemente-NapimogaAlpdogan KantarciMarcelo Henrique NapimogaThomas E Van DykePublished in: Journal of immunology (Baltimore, Md. : 1950) (2024)
Epoxyeicosatrienoic acids (EETs) and other epoxy fatty acids are short-acting lipids involved in resolution of inflammation. Their short half-life, due to its metabolism by soluble epoxide hydrolase (sEH), limits their effects. Specialized proresolving mediators (SPMs) are endogenous regulatory lipids insufficiently synthesized in uncontrolled and chronic inflammation. Using an experimental periodontitis model, we pharmacologically inhibited sEH, examining its impact on T cell activation and systemic SPM production. In humans, we analyzed sEH in the gingival tissue of periodontitis patients. Mice were treated with sEH inhibitor (sEHi) and/or EETs before ligature placement and treated for 14 d. Bone parameters were assessed by microcomputed tomography and methylene blue staining. Blood plasma metabololipidomics were carried out to quantify SPM levels. We also determined T cell activation by reverse transcription-quantitative PCR and flow cytometry in cervical lymph nodes. Human gingival samples were collected to analyze sEH using ELISA and electrophoresis. Data reveal that pharmacological sEHi abrogated bone resorption and preserved bone architecture. Metabololipidomics revealed that sEHi enhances lipoxin A4, lipoxin B4, resolvin E2, and resolvin D6. An increased percentage of regulatory T cells over Th17 was noted in sEHi-treated mice. Lastly, inflamed human gingival tissues presented higher levels and expression of sEH than did healthy gingivae, being positively correlated with periodontitis severity. Our findings indicate that sEHi preserves bone architecture and stimulates SPM production, associated with regulatory actions on T cells favoring resolution of inflammation. Because sEH is enhanced in human gingivae from patients with periodontitis and connected with disease severity, inhibition may prove to be an attractive target for managing osteolytic inflammatory diseases.
Keyphrases
- endothelial cells
- regulatory t cells
- oxidative stress
- bone loss
- bone mineral density
- flow cytometry
- fatty acid
- newly diagnosed
- lymph node
- transcription factor
- palliative care
- gene expression
- end stage renal disease
- bone regeneration
- soft tissue
- dendritic cells
- pluripotent stem cells
- chronic kidney disease
- single cell
- poor prognosis
- ejection fraction
- genome wide
- immune response
- high fat diet induced
- type diabetes
- dna methylation
- deep learning
- adipose tissue
- artificial intelligence
- machine learning
- early stage
- metabolic syndrome
- drug induced
- skeletal muscle
- body composition
- patient reported outcomes